4
Changes in Ownership
Celldex Therapeutics, Inc. Filed Acc 0001415889-22-008896
SVP OF CORP AFFAIRS & ADMIN. sold 32,667 shares at an average $36.72 ($1,199,510)
- SVP OF CORP AFFAIRS & ADMIN. acquired 32,667 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cavanaugh Sarah SVP OF CORP AFFAIRS & ADMIN. | 2022-08-17 | Option exercise | +31,312 | $2.78 | $87,047 | 32,596 | D |
| Cavanaugh Sarah SVP OF CORP AFFAIRS & ADMIN. | 2022-08-17 | Sale | −31,312 | $36.73 | $1,150,221 | 1,284 | D |
| Cavanaugh Sarah SVP OF CORP AFFAIRS & ADMIN. | 2022-08-18 | Option exercise | +1,355 | $9.02 | $12,217 | 2,639 | D |
| Cavanaugh Sarah SVP OF CORP AFFAIRS & ADMIN. | 2022-08-18 | Sale | −1,355 | $36.38 | $49,289 | 1,284 | D |
| Derivatives | |||||||
| Cavanaugh Sarah SVP OF CORP AFFAIRS & ADMIN. | 2022-08-17 | Option exercise · Incentive Stock Option | −31,312 | 10,750 | D | ||
| Cavanaugh Sarah SVP OF CORP AFFAIRS & ADMIN. | 2022-08-18 | Option exercise · Incentive Stock Option | −1,355 | 10,103 | D | ||
| Open-market sales · 32,667 sh · avg $36.72 · $1,199,510 | |||||||
Loading xslF345X03/form4-08192022_010836.xml…